Literature DB >> 7362736

Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction.

J G Collier, R J Dobbs, I Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7362736      PMCID： PMC1429875          DOI： 10.1111/j.1365-2125.1980.tb04837.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  The clinical pharmacology of oral and inhaled salbutamol.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

2.  Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator.

Authors:  M C Kennedy; W T Simpson
Journal:  Br J Dis Chest       Date:  1969-07

3.  Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  D A Warrell; D G Robertson; J N Howes; M E Conolly; J W Paterson; L J Beilin; C T Dollery
Journal:  Br Med J       Date:  1970-01-10

4.  The fate of isoprenaline administered by pressurized aerosols.

Authors:  E W Blackwell; M E Conolly; D S Davies
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

5.  The bronchodilator action of salbutamol in asthmatics.

Authors:  A Schumann; H Herxheimer
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401
  5 in total
  17 in total

1.  Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device.

Authors:  D M Newnham; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

2.  Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.

Authors:  D M Newnham; A Grove; D G McDevitt; B J Lipworth
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

3.  Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.

Authors:  B J Lipworth; D G McDevitt; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

4.  Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; T A Moreland; A D Struthers; G A Clark; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Cardiac effects of salbutamol given by air driven nebuliser at home.

Authors:  J J Gilmartin; D Veale; A Murray; P C Adams; G J Gibson
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

Review 6.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 7.  New perspectives on inhaled drug delivery and systemic bioactivity.

Authors:  B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

8.  Bioavailability of salbutamol.

Authors:  B J Lipworth; A Grove
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

9.  Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.

Authors:  E T Smyth; I D Pavord; C S Wong; A F Wisniewski; J Williams; A E Tattersfield
Journal:  BMJ       Date:  1993-02-27

10.  Systemic effects of salbutamol and salmeterol in patients with asthma.

Authors:  J A Bennett; E T Smyth; I D Pavord; P J Wilding; A E Tattersfield
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.